The AHA advisory on saturated fats, anticoagulant use, gene abnormalities in survivors of cardiac arrest, lliraglutide, and a new monoclonal antibody for CV protection are discussed this week.

Drs Naveen Pererira, Paul Friedman, and Abhishek Deshmukh discuss how clinical trials have shaped preferences for pacemakers, defibrillators, and optimal medical therapy in the treatment of nonischemic cardiomyopathy.

Bleeding risk of ASA in the elderly, stopping statins, ADA wrap-up, and the importance of education level for CV health are the topics discussed by Dr John Mandrola in this week's podcast

Dr Virend Somers sits down with Dr Jay Widmer to parse the relationships between central and obstructive sleep apnea and cardiovascular diseases--and the best treatment strategies for each.

Clinical-trial integrity, sports participation with an ICD, valve-in-valve TAVR, NOAC dosing, and PA and NP involvement in care are discussed this week.

Dr Andrew Kaunitz discusses hormone receptor therapy in menopausal women and the relationship between ovarian function duration and risk for heart failure.

Chocolate and AF, CTO PCI, restarting anticoagulation after ICH, novel LDL-lowering techniques, and anabolic steroid harms are discussed in this week's podcast.

Dr JoAnn Manson summarizes key evidence showing that 'what's good for the heart is good for the brain.'

MRI in patients with cardiac devices, statins in the elderly, deprescribing, CRT and radial artery catheterization are discussed in this week’s podcast.

Dr Harrington leads a roundtable discussion on how to attract women and minorities to the practice of cardiology so the physician makeup can better reflect the patient makeup.